Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (9744)	4/30/1999 12:05:00 AM
From: Slugger	Read Replies (3) \| Respond to of 17367

>>Manana?<< Check out this site and type in XOMA: thomsoninvest.net I've been checking it daily for the past week or so. Prior to today the chart hadn't shown any institutional interest in XOMA. Today is the first time it's shown institutional interest, so maybe something is up.

To: aknahow who wrote (9744)	4/30/1999 8:53:00 AM
From: Robert K.	Respond to of 17367

I continue to find this header from the just past Biocentury meeting of interest. "— Beginning to release late-stage data from multiple trials of Neuprex, starting with preliminary Phase III data in children with severe meningococcemia, as well as Phase II results for hu1124 humanized MAb in plaque psoriasis, partnered with Genentech Inc. (GNE)." >begining to (indicating more than one)(indicating another p3) >starting with meningo (thats the expectation) >preliminary P3 data (now what does "preliminary" mean?) > a slip of the tongue, or a miss communication, or just nothing? hmmmmmmmm. standard K disclaimers